Trial Identifier: | D9090C00005 |
Sponsor: | AstraZeneca |
Collaborator: |
Parexel
|
NCTID:: | NCT05512806 |
Start Date: | August 2022 |
Primary Completion Date: | November 2022 |
Study Completion Date: | November 2022 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
Language | Description |
English Version | |
Spanish (US) Translation |
Country | Location |
---|---|
US, MD | Brooklyn, MD, US, 21225 |